- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06739954
Effectiveness of DN With or Without Mulligan Two Leg Rotation Technique on Pain ROM and Joint Dysfunction in KO
December 13, 2024 updated by: Muhammad Naveed Babur, Superior University
Effectiveness of Dry Needling With or Without Mulligan Two Leg Rotation Technique on Pain, Range of Motion and Joint Dysfunction in Knee Osteoarthritis
The objective of study is to determine the effectiveness of dry needling with or without mulligan two leg rotation technique on pain, range of motion and joint dysfunction in knee osteoarthritis.
The study will be a single blinded randomized controlled trial conducted at the Physical Therapy Department of Hussain Memorial Hospital, focusing on the treatment of knee osteoarthritis in adults aged 40 to 80 years.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The selection criteria will include patients with a confirmed diagnosis of knee osteoarthritis according to the Kellgren and Lawrence classification system, persistent symptoms for at least 6 months, and willingness to participate in the study.
Exclusion criteria will include patients with other joint pathologies, severe psychiatric disorders, unstable medical conditions, or currently enrolled in another clinical trial.
The sample size will be 40 patients, and divided into two groups, with Group A receiving dry needling combined with Mulligan two-leg rotation technique and Group B receiving only dry needling.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan
- Ghurki Trust and Teaching Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult patients with age 18-65 diagnosed with chronic coccydynia for at least 3 months were recruited.
- Participants who will be willing & able to adhere to the study protocol.
- Including participants who will be attending follow-up appointments & completing outcome measures.
- Participants who will be able to understand & provide written informed consent.
- Participants with a complete screening of other medical conditions and previous medical records.
Exclusion Criteria:
- Participants with previous surgery on the coccyx or lumbosacral spine, pregnancy or breastfeeding, history of bleeding disorders or anticoagulant use, active infection, or significant medical condition that could pose a safety risk during the procedures (GIB or CESI) was omitted.
- Patients above the age of 65 were eliminated to reduce confounding by age-related health concerns and to provide a more homogenous study population for more accurate treatment outcomes.
- Participants with neurological conditions affecting pain perception or sensation were excluded.
- Participants with known allergies to medications used in the study (local anesthetic, steroid for injections) were not part of the study.
- Participation in another interventional clinical trial within the past 3 months was not included.
- Participants who were unable to safely undergo fluoroscopy were also excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interventional group I
|
The participants will undergo Mulligan's Two Leg Rotation technique, performing 10 repetitions with a 30-second hold for each repeat.
There will be a 1-minute rest period between each stretch.
The therapist positions themselves on the affected side of the supine patient lying on the treatment table and holds onto the side of the table with their hand on the opposite side.
Both legs will be bent so that the feet are raised from the plinth.
Maintaining the subject's shoulders on the bed, he gradually moves the subject's legs to the side, considering the restricted flexibility of the hamstring muscles.
Once the patient reaches their maximum, the therapist applies extra pressure to sustain the posture for 30 seconds.
Then, the legs are lowered to the plinth.
A 1-minute interval was provided between each stretch, and the stretches were performed for a total of 10 repetitions.
The identical technique is performed on the opposite side to address insufficient flexibility in the hamstrings.
|
|
Active Comparator: Interventional group II
|
The DN technique, based on previous research, involved slowly inserting and removing the needle in the muscle or tendon to elicit a specific response.
This response could be a local twitch, a dull ache, a feeling of heaviness or distension, or the reproduction of the participant's symptoms.
The needle is manipulated in and out of the targeted tissue five times every five minutes for a total of fifteen minutes.
After the treatment, sterile gauze is applied and pressed on the DN site, and sterile non-stick pads are used to cover the treated areas.
The number of needles used varied depending on the participant's condition.
The knee muscles that will be included in the dry needling intervention are the Quadriceps and Hamstrings .
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale (VAS)
Time Frame: 12 Months
|
It is a tool used to measure pain intensity.
It consists of a 10cm line with two endpoints representing 0, indicating 'no pain,' and 10, indicating 'pain as bad as it could possibly be.' Patients are asked to rate their current level of pain by marking the line accordingly.
The distance in centimeters from the 'no pain marker' or zero to the marked point is measured using a ruler.
This measurement provides a pain intensity score on a scale of 0 to 10.
For example, a score of 6 out of 10 (or 6/10) indicates a pain level of 6.
|
12 Months
|
|
Western Ontario and McMaster universities osteoarthritis (WOMAC) index
Time Frame: 12 Months
|
This self-administered questionnaire was presented using a five-point ordinal scale with five categorical responses (numerical value of 0-4).
WOMAC was designed to measure perceived pain, stiffness and dysfunction.
High WOMAC scores reflect greater severity across the three measured domains.
WOMAC has moderate-to-excellent reliability and validity to test pain, stiffness and function, especially in patients with hip or knee OA
|
12 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2024
Primary Completion (Actual)
August 1, 2024
Study Completion (Estimated)
February 28, 2025
Study Registration Dates
First Submitted
December 13, 2024
First Submitted That Met QC Criteria
December 13, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 13, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSRSW/Batch-Fall22/773
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.